Adverse Events Associated with the Clinical Use of Bee Venom: A Review

Toxins (Basel). 2022 Aug 18;14(8):562. doi: 10.3390/toxins14080562.

Abstract

Bee venom is used to treat various diseases but can cause a tickling sensation and anaphylaxis during clinical treatment. Adverse events (AEs) associated with bee venom may vary depending on the dosage, method, route of administration, and the country, region, and user. We summarized the AEs of bee venom used in various ways, such as by the injection of extracts, venom immunotherapy (VIT), live bee stings, or external preparations. We conducted a search in eight databases up to 28 February 2022. It took one month to set the topic and about 2 weeks to set the search terms and the search formula. We conducted a search in advance on 21 February to see if there were omissions in the search terms and whether the search formula was correct. There were no restrictions on the language or bee venom method used and diseases treated. However, natural stings that were not used for treatment were excluded. A total of 105 studies were selected, of which 67, 26, 8, and 4 were on the injection of extracts, VIT, live bee stings, and external preparation, respectively. Sixty-three studies accurately described AEs, while 42 did not report AEs. Thirty-five randomized controlled trials (RCTs) were evaluated for the risk of bias, and most of the studies had low significance. A large-scale clinical RCT that evaluates results based on objective criteria is needed. Strict criteria are needed for the reporting of AEs associated with bee venom.

Keywords: adverse effect; adverse events; bee venom; bee venom acupuncture.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anaphylaxis* / chemically induced
  • Anaphylaxis* / drug therapy
  • Bee Venoms*
  • Desensitization, Immunologic / methods
  • Humans
  • Insect Bites and Stings* / complications
  • Wasp Venoms

Substances

  • Bee Venoms
  • Wasp Venoms

Grants and funding

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT)—No. NRF-2022R1I1A3068255.